ClinicalTrials.Veeva

Menu

microRNA Profiles Identification in Adeno Carcinoma Prostate Cancer

A

Assuta Medical Center

Status

Unknown

Conditions

Prostate Carcinosarcoma

Treatments

Biological: High PSA levels

Study type

Observational

Funder types

Other

Identifiers

NCT02964351
0093-16-ASMC

Details and patient eligibility

About

In our study, the investigators want to find correlation between circulating miRNAs associated with prostate cancer metastases to bones and to lymph nodes separately with results of 68Ga-PSMA ligand PET (positron emission computed) imaging.

Enrollment

120 estimated patients

Sex

Male

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Proven Adeno-carcinoma
  • Underwent prostatectomy and still present high PSA levels
  • Refered to PSMA exam.

Exclusion criteria

  • Below 18 years old
  • HIV/HBV (hepatitis B virus)/HCV (hepatitis C virus) positive
  • Additional malignancy during the past five years.

Trial design

120 participants in 1 patient group

High PSA (prostate-specific antigen) levels
Treatment:
Biological: High PSA levels

Trial contacts and locations

0

Loading...

Central trial contact

Natalia Goldberg, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems